NEW YORK (GenomeWeb) – Australian molecular diagnostics firm Genetic Technologies today announced it has regained compliance to continue listing its shares on the Nasdaq. 

Genetic Technologies received a warning letter from Nasdaq in November 2014 telling the firm it did not meet a listing requirement of at least $2.5 million in stockholder equity. The company said today that it had net assets of about A$21 million (about US$16.5 million) as of March 31, allowing it continue listing its stock on the Nasdaq.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The Atlantic reports that genetic counselors are coping with an influx of patients seeking advice on their direct-to-consumer genetic test results.

A small study finds differences between three genomic prostate cancer tests, Medscape reports.

In Nature this week: shared genetic architecture for asthma and allergic diseases, and more.

A survey of Canadians finds them to be divided on genetically modified food, the Ottawa Citizen reports.